Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease

What is it about?

The Laboratory-based Intermountain Validated Exacerbation (LIVE) Score has been associated with mortality and hospitalization risk in patients with Chronic Obstructive Pulmonary Disease. Whether and how the LIVE Score changes over time was previously unknown. In this study, we show that patients with a low risk LIVE Score remain low risk over years. In contrast, patients with a high risk LIVE Score have a high risk of death, and if they survive, they recover to a medium risk LIVE Score. This characterization is a step forward in our understanding of how we may use the LIVE Score in order to improve the lives of people with COPD.

Featured Image